新的天然免疫保护分子——PLUNC家族蛋白

在呼吸道上皮与消化道上皮的表面,覆盖有一层由免疫保护分子所组成的蛋白质混合物,在上皮组织与外界各种信号之间,它们起着信号传递中介与信号执行分子的作用.我们新克隆的NASG基因为这一混合物添加了新的成员,对其结构与功能分析表明:它属于腭、肺及鼻咽上皮克隆（PLUNC）家族中SPLUNC1的全新转录本.目前发现人类PLUNC家族至少有8个以上成员,分布在人类20号染色体大约300 kb的狭窄区域,它们具有杀菌\渗透增强蛋白结构域,在进化上高度保守,每个成员分别在呼吸道上皮的不同部位特异性表达,具有潜在的结合细菌脂多糖的功能,能对外来物理及化学刺激做出反应,以分泌蛋白的形式进入鼻咽分泌物或唾液中,部分家族成员可能具有抗微生物、清除有害化学物质、抗肿瘤等多重功效.以上说明,PLUNC家族可能是上呼吸道的一种新的天然免疫保护分子,在维持上呼吸道的正常生理活动中起重要作用.     

综述:PLUNC蛋白家族在抑制鼻咽上皮“炎-癌”演进中的作用和机制

人类鼻咽黏膜表面的分泌物中富含天然免疫蛋白,腭、肺及鼻咽上皮克隆(palate,lung and nasal epithelium clone,PLUNC)蛋白家族成员SPLUNC1和LPLUNC1就是其中的重要组成部分,这两个蛋白在鼻咽上皮相对特异高表达,它们都具有杀菌/渗透增强蛋白(bactericidal/permeability-increasing protein,BPI)结构域,可通过BPI结构域与细菌脂多糖(lipopolysaccharides,LPS)结合从而直接杀灭或抑制细菌生长,也可以有效抑制EB病毒(Epstein-Barr virus,EBV)等致癌微生物对鼻咽上皮的侵袭从而发挥其免疫防御功能．它们还可以通过抑制IL-6等炎症因子的分泌和NF-κB、STAT3等炎症相关通路的激活,阻止鼻咽部的慢性炎症反应及鼻咽上皮的恶性转化．在鼻咽癌细胞中重新表达PLUNC蛋白,可以通过促分裂素原活化蛋白激酶(Mitogen-activated protein kinase,MAPK)或miR-141-PTEN-AKT等信号通路抑制鼻咽癌细胞的增殖,促进鼻咽癌细胞的凋亡．进一步深入研究PLUNC蛋白家族在鼻咽癌发病中的作用机制,对指导鼻咽癌的防治具有重要的意义．     

PLUNC蛋白家族在抑制鼻咽上皮“炎-癌”演进中的作用和机制

人类鼻咽黏膜表面的分泌物中富含天然免疫蛋白,腭、肺及鼻咽上皮克隆(palate,lung and nasal epithelium clone,PLUNC)蛋白家族成员SPLUNC1和LPLUNC1就是其中的重要组成部分,这两个蛋白在鼻咽上皮相对特异高表达,它们都具有杀菌/渗透增强蛋白(bactericidal/permeability-increasing protein,BPI)结构域,可通过BPI结构域与细菌脂多糖(lipopolysaccharides,LPS)结合从而直接杀灭或抑制细菌生长,也可以有效抑制EB病毒(Epstein-Barr virus,EBV)等致癌微生物对鼻咽上皮的侵袭从而发挥其免疫防御功能.它们还可以通过抑制IL-6等炎症因子的分泌和NF-κB、STAT3等炎症相关通路的激活,阻止鼻咽部的慢性炎症反应及鼻咽上皮的恶性转化.在鼻咽癌细胞中重新表达PLUNC蛋白,可以通过促分裂素原活化蛋白激酶(Mitogen-activated protein kinase,MAPK)或miR-141-PTEN-AKT等信号通路抑制鼻咽癌细胞的增殖,促进鼻咽癌细胞的凋亡.进一步深入研究PLUNC蛋白家族在鼻咽癌发病中的作用机制,对指导鼻咽癌的防治具有重要的意义.     

SPLUNC1多肽抗体的设计、制备与鉴定

通过设计SPLUNC1蛋白的一段多肽,快速制备抗SPLUNC1的多肽抗体,检测多肽抗体的性能,为SPLUNC1的功能研究提供可靠的平台. 用DS Gene1.1软件分析SPLUNC1蛋白的跨膜结构域、二级结构、疏水性、亲水性以及抗原性等,综合考虑抗体设计的其它因素,设计出两段15～20个氨基酸的多肽.将合成后的多肽与钥孔戚血蓝素（keyhole limpet hemocyanin,KLH）偶联,同时初筛出宿主血清与SPLUNC1无交叉反应的新西兰家兔,用与KLH相连的SPLUNC1多肽免疫家兔,2个月后获取血清,亲和纯化出抗SPLUNC1多肽抗体,通过ELISA法检测其效价,免疫印迹与免疫组化检测其特异性与适用范围.通过该方法得到了高效价与高特异性的SPLUNC1多克隆特异性抗体,ELISA法测定其效价可达到1∶10⁵,通过对包含有PLUNC家族不同成员的蛋白混合物进行Western印迹检测证明,该多肽抗体具有较高的特异性,不与同一家族中的其它蛋白发生交叉反应,而且该抗体可用于免疫组化,说明所制备的分泌性蛋白SPLUNC1抗体具有高特异、高效价等特点,将为SPLUNC1基因的功能研究提供有用的研究材料.     

成纤维细胞生长因子的特性与分子功能

成纤维细胞生长因子(FGFs)是一类蛋白质活性肽,在有机体内外显示广谱的生物学活性和功能,在生物发育学、生理学与临床药理学方面具有重要的作用和意义．对 FGFs 家族成员肽的特征特性,FGFs 的染色体定位、基因结构与功能,FGFs 的信号分子作用与促分裂素作用,FGFs 的作用受体、主动和被动调节与拮抗机理进行了综述．     

细胞调亡是半胱天冬酶参与的复杂过程

自从发现线虫(Caenorhabditis elegan)的CED蛋白与哺乳动物的白介素-1β转换酶(ICE)有相似作用以来[1],已有13种半胱天冬酶家族成员先后被发现或克隆[2](表1).半胱天冬酶(caspase)分为启动型和执行型,前者接受死亡信号、启动凋亡或激活下游的分子,后者则降解细胞骨架、蛋白质、核酸等.     

Bcl—2家族蛋白与细胞凋亡

Bcl 2家族蛋白是在细胞凋亡过程中起关键性作用的一类蛋白质。在线粒体上 ,Bcl 2家族蛋白通过与其他凋亡蛋白的协同作用 ,调控线粒体结构与功能的稳定性 ,发挥着细胞凋亡“主开关”的作用。Bcl 2家族包括两类蛋白质 :一类是抗凋亡蛋白 ,另一类是促凋亡蛋白。在细胞凋亡时 ,Bcl 2家族中的促凋亡蛋白成员发生蛋白质的加工修饰 ,易位到线粒体的外膜上 ,引起细胞色素c、凋亡诱导因子等其他促凋亡因子的释放 ,导致细胞凋亡 ;而平时被隔离在线粒体等细胞器内的该家族的抗凋亡蛋白成员则抑制细胞色素c和凋亡诱导因子等促凋亡因子的释放 ,具有抑制细胞凋亡的功能。但一旦这类抗凋亡蛋白成员与激活的促凋亡蛋白发生相互作用后 ,便丧失了对细胞凋亡的抑制作用 ,造成线粒体等细胞器的功能丧失和细胞器内促凋亡因子的释放 ,导致细胞凋亡。现以Bcl 2家族调控细胞凋亡的最新研究进展为基础 ,对Bcl 2家族成员及其蛋白质结构、分布和调控细胞凋亡的分子机制进行综述。     

葡萄糖调节蛋白58的结构和功能

葡萄糖调节蛋白58是蛋白二硫化物异构酶家族成员之一。此蛋白在结构上具有两个硫氧还蛋白结构域CGHC,在功能上作为一种分子伴侣调节蛋白质的折叠和转运,参与重要物质的组成,STAT3的信号转导和神经细胞的保护作用。它在多种肿瘤细胞中呈高表达,对肿瘤细胞的抗化疗药物的性质及抗原表达有重要意义。     

BcL2蛋白质家族——定位与转位

Bcl-2蛋白质家族的抗凋亡和促凋亡成员,在线粒体水平上决定细胞的存活或死亡.在正常细胞中,这些成员呈现功能适应性的细胞内分布;抗凋亡成员主要定位于细胞内膜系特别是线粒体外膜上：但绝大多数促凋亡成员主要分布于细胞浆中.细胞接受死亡信号后,Bcl-2家族成员本身受到一系列的调节,如磷酸化、裂解、蛋白质-蛋白质相互作用等,结果之一是促凋亡成员发生细胞内定位的改变,从细胞浆转位于线粒体膜上,并引发线粒体功能异常及其内外膜间致凋亡因子的释放,最终导致细胞凋亡.     

鱼类Toll样受体及其信号传导的研究进展

鱼类是脊椎动物中的一个重要类群, 在其生存与进化的过程中, 免疫系统担负着保护鱼类免受病原感染的重任, 其中Toll样受体家族等介导的先天性免疫是鱼类抗病免疫的第一道防线, 并在连接先天性免疫与获得性免疫反应中起着桥梁作用. 虽然从无脊椎动物到高等脊椎动物, Toll样受体家族内多数成员在蛋白质结构与功能上都较为保守, 但是鱼类作为最低等的脊椎动物, 在其进化过程中又形成了一些特有Toll样受体分子, 其剪接类型也更丰富; 鱼类Toll样受体家族介导的免疫识别、免疫信号传导、激活和调控方式与高等脊椎动物也不尽相同. 文章主要综述了鱼类Toll样受体的结构、种类、功能、多样性、免疫信号传导及其调控特点, 为深入了解鱼类的免疫反应奠定基础.       

Functional roles of SPLUNC1 in the innate immune response against Gram-negative bacteria

PLUNC (palate, lung and nasal epithelium clone)-associated gene originally referred to one gene, but now has been extended to represent a gene family that consists of a number of genes with peptide sequence homologies and predicted structural similarities. PLUNC-like proteins display sequence homology with BPI (bactericidal/permeability-increasing protein), a 456-residue cationic protein produced by precursors of polymorphonuclear leucocytes that have been shown to possess both bactericidal and LPS (lipopolysaccharide)-binding activities. The human PLUNC is also known as LUNX (lung-specific X protein), NASG (nasopharyngeal carcinoma-related protein) and SPURT (secretory protein in upper respiratory tract). The gene originally named PLUNC is now recognized as SPLUNC1. Its gene product SPLUNC1 is a secretory protein that is abundantly expressed in cells of the surface epithelium in the upper respiratory tracts and secretory glands in lung, and in the head and the neck region. The functional role of SPLUNC1 in innate immunity has been suggested but not clearly defined. The present review describes recent findings that support antimicrobial and anti-inflammatory functions of SPLUNC1 in Gram-negative bacteria-induced respiratory infection.     

Distribution of human PLUNC/BPI fold-containing (BPIF) proteins

Although gene expression studies have shown that human PLUNC (palate, lung and nasal epithelium clone) proteins are predominantly expressed in the upper airways, nose and mouth, and proteomic studies have indicated they are secreted into airway and nasal lining fluids and saliva, there is currently little information concerning the localization of human PLUNC proteins. Our studies have focused on the localization of three members of this protein family, namely SPLUNC1 (short PLUNC1), SPLUNC2 and LPLUNC1 (long PLUNC1). Western blotting has indicated that PLUNC proteins are highly glycosylated, whereas immunohistochemical analysis demonstrated distinct patterns of expression. For example, SPLUNC2 is expressed in serous cells of the major salivary glands and in minor mucosal glands, whereas SPLUNC1 is expressed in the mucous cells of these glands. LPLUNC1 is a product of a population of goblet cells in the airway epithelium and nasal passages and expressed in airway submucosal glands and minor glands of the oral and nasal cavities. SPLUNC1 is also found in the epithelium of the upper airways and nasal passages and in airway submucosal glands, but is not co-expressed with LPLUNC1. We suggest that this differential expression may be reflected in the function of individual PLUNC proteins.     

Characterisation and expression of SPLUNC2, the human orthologue of rodent parotid secretory protein

We recently described the Palate Lung Nasal Clone (PLUNC) family of proteins as an extended group of proteins expressed in the upper airways, nose and mouth. Little is known about these proteins, but they are secreted into the airway and nasal lining fluids and saliva where, due to their structural similarity with lipopolysaccharide-binding protein and bactericidal/permeability-increasing protein, they may play a role in the innate immune defence. We now describe the generation and characterisation of novel affinity-purified antibodies to SPLUNC2, and use them to determine the expression of this, the major salivary gland PLUNC. Western blotting showed that the antibodies identified a number of distinct protein bands in saliva, whilst immunohistochemical analysis demonstrated protein expression in serous cells of the major salivary glands and in the ductal lumens as well as in cells of minor mucosal glands. Antibodies directed against distinct epitopes of the protein yielded different staining patterns in both minor and major salivary glands. Using RT-PCR of tissues from the oral cavity, coupled with EST analysis, we showed that the gene undergoes alternative splicing using two 5′ non-coding exons, suggesting that the gene is regulated by alternative promoters. Comprehensive RACE analysis using salivary gland RNA as template failed to identify any additional exons. Analysis of saliva showed that SPLUNC2 is subject to N-glycosylation. Thus, our study shows that multiple SPLUNC2 isoforms are found in the oral cavity and suggest that these proteins may be differentially regulated in distinct tissues where they may function in the innate immune response.     

Tissue distribution of the secretory protein, SPLUNC1, in the human fetus

We previously identified a tissue-specific gene, short palate, lung, and nasal epithelium clone 1 (SPLUNC1), in nasopharyngeal epithelial tissues. SPLUNC1 was differentially expressed in nasopharyngeal carcinoma. Bioinformatic analysis revealed that SPLUNC1 has the bactericidal permeability-increasing protein/lipid-binding protein (BPI/LBP) domain and a 19 amino acid signal peptide, which suggest that it is a secretory protein. Its precise cellular localization in the respiratory tract is mainly in mucous cells and ducts of submucosal glands. However, little is known about its expression pattern in various human tissues. We generated a highly specific antibody and analyzed its distribution in the human fetus by immunohistochemistry to more precisely determine SPLUNC1 protein localization in human tissues. The results were further validated by RT-PCR. Our results showed that SPLUNC1 protein is expressed at not only the serous glands and epithelium of the upper respiratory tract and digestive tract, but also in the oculi of human embryos. Interestingly, we also found positive staining in fetus adipose tissue, a result not previously reported in studies of adult human tissues. Western blot analysis detected a 24 kDa SPLUNC1 protein in the compounds of nasopharyngeal secretions. This secretory protein was also detected in saliva and tears. Our research suggests that SPLUNC1 protein may not only be an antimicrobial peptide that plays an important role in the maintenance of homeostasis in the upper respiratory tract, oculi, and alimentary tract, it may also be important in the development and lipid metabolism of the adipose tissue.     

Phylogenetic and evolutionary analysis of the PLUNC gene family

The PLUNC family of human proteins are candidate host defense proteins expressed in the upper airways. The family subdivides into short (SPLUNC) and long (LPLUNC) proteins, which contain domains predicted to be structurally similar to one or both of the domains of bactericidal/permeability-increasing protein (BPI), respectively. In this article we use analysis of the human, mouse, and rat genomes and other sequence data to examine the relationships between the PLUNC family proteins from humans and other species, and between these proteins and members of the BPI family. We show that PLUNC family clusters exist in the mouse and rat, with the most significant diversification in the locus occurring for the short PLUNC family proteins. Clear orthologous relationships are established for the majority of the proteins, and ambiguities are identified. Completion of the prediction of the LPLUNC4 proteins reveals that these proteins contain approximately a 150-residue insertion encoded by an additional exon. This insertion, which is predicted to be largely unstructured, replaces the structure homologous to the 40s hairpin of BPI. We show that the exon encoding this region is anomalously variable in size across the LPLUNC proteins, suggesting that this region is key to functional specificity. We further show that the mouse and human PLUNC family orthologs are evolving rapidly, which supports the hypothesis that these proteins are involved in host defense. Intriguingly, this rapid evolution between the human and mouse sequences is replaced by intense purifying selection in a large portion of the N-terminal domain of LPLUNC4. Our data provide a basis for future functional studies of this novel protein family.     

Distant cousins: genomic and sequence diversity within the BPI fold-containing (BPIF)/PLUNC protein family

PLUNC (palate, lung and nasal epithelium clone) proteins make up the largest branch of the BPI (bactericidal/permeability-increasing protein)/LBP (lipopolysaccharide-binding protein) family of lipid-transfer proteins. PLUNCs make up one of the most rapidly evolving mammalian protein families and exhibit low levels of sequence similarity coupled with multiple examples of species-specific gene acquisition and gene loss. Vertebrate genomes contain multiple examples of genes that do not meet our original definition of what is required to be a member of the PLUNC family, namely conservation of exon numbers/sizes, overall protein size, genomic location and the presence of a conserved disulfide bond. This suggests that evolutionary forces have continued to act on the structure of this conserved domain in what are likely to be functionally important ways.     

Differential localisation of BPIFA1 (SPLUNC1) and BPIFB1 (LPLUNC1) in the nasal and oral cavities of mice

Despite being initially identified in mice, little is known about the sites of production of members of the BPI fold (BPIF) containing (PLUNC) family of putative innate defence proteins in this species. These proteins have largely been considered to be specificaly expressed in the respiratory tract, and we have recently shown that they exhibit differential expression in the epithelium of the proximal airways. In this study, we have used species-specific antibodies to systematically localize two members of this protein family; BPIFA1 (PLUNC/SPLUNC1) and BPIFB1 (LPLUNC1) in adult mice. In general, these proteins exhibit distinct and only partially overlapping localization. BPIFA1 is highly expressed in the respiratory epithelium and Bowman??s glands of the nasal passages, whereas BPIFB1 is present in small subset of goblet cells in the nasal passage and pharynx. BPIFB1 is also present in the serous glands in the proximal tongue where is co-localised with the salivary gland specific family member, BPIFA2E (parotid secretory protein) and also in glands of the soft palate. Both proteins exhibit limited expression outside of these regions. These results are consistent with the localization of the proteins seen in man. Knowledge of the complex expression patterns of BPIF proteins in these regions will allow the use of tractable mouse models of disease to dissect their function.     

Antimicrobial activity of PLUNC protects against Pseudomonas aeruginosa infection

Epithelial antimicrobial activity may protect the lung against inhaled pathogens. The bactericidal/permeability-increasing protein family has demonstrated antimicrobial activity in vitro. PLUNC (palate, lung, and nasal epithelium associated) is a 25-kDa secreted protein that shares homology with bactericidal/permeability-increasing proteins and is expressed in nasopharyngeal and respiratory epithelium. The objective of this study was to determine whether PLUNC can limit Pseudomonas aeruginosa infection in mice. Transgenic mice (Scgb1a1-hPLUNC) were generated in which human PLUNC (hPLUNC) was directed to the airway epithelium with the Scgb1a1 promoter. The hPLUNC protein (hPLUNC) was detected in the epithelium throughout the trachea and bronchial airways and in bronchoalveolar lavage fluid. Bronchoalveolar lavage fluid from transgenic mice exhibited higher antibacterial activity than that from wild type littermates in vitro. After in vivo P. aeruginosa challenge, Scgb1a1-hPLUNC transgenic mice displayed enhanced bacterial clearance. This was accompanied by a decrease in neutrophil infiltration and cytokine levels. More importantly, the overexpressed hPLUNC in Scgb1a1-hPLUNC transgenic mouse airway significantly enhanced mouse survival against P. aeruginosa-induced respiratory infection. These data indicate that PLUNC is a novel antibacterial protein that likely plays a critical role in airway epithelium-mediated innate immune response.